focus -WSS

focus

author：explore 2025-10-02 23:48:18 - browse：2

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

hotspot

WSS

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Advances in CAR

How to fix cancer clinical trials' diversity problem

With heat waves through August, officials warn of health risks

Sage considers ways to reduce costs following FDA rejection

House transparency, PBM reform bill gains bipartisan support

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Guidelines to prevent youth baseball injuries need more muscle

St. Louis police protesters begin picking up checks in $4.9 million settlement

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Covid hospitalizations on the rise, Humana says

Apple is now the first public company to be valued at $3 trillion

A rare thyroid diagnosis led to unexpected, all

Medical records are filled with copy

Humana sues Biden admin over Medicare Advantage audit rule

leisure time

Trump used to be more articulate. What could explain the change?

How CRISPR works, explained in two minutes

Why Novartis is changing the name of its research labs

Amazon on where the company's health care bets are headed next

Doctors are clamoring for more clarity on Paxlovid prescribing

What American doctors can learn from their Israeli counterparts

hotspot

focus

hotspot

Wikipedia